{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:52:08Z","timestamp":1791312728101,"version":"4.3.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009232","name":"Debreceni Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024601","name":"University of Debrecen Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100369","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:08:10Z","timestamp":1775030890000},"page":"100369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Autoantibodies in the follow-up of autoimmune hepatitis"],"prefix":"10.1016","volume":"12","author":[{"given":"G\u00e1bor","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Bencze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"Demeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"P\u00e9nzes-Daku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3za","family":"F\u00f6ldesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-726X","authenticated-orcid":false,"given":"P\u00e9ter","family":"Antal-Szalm\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2026.100369_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102565","article-title":"Unmet needs in autoimmune liver diseases","volume":"95","author":"Kolev","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jtauto.2026.100369_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100125","article-title":"Impact of genetic and environmental factors on autoimmune hepatitis","volume":"4","author":"Zachou","year":"2021","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100369_bib4","first-page":"659","article-title":"Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells","volume":"12","author":"Qiu","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib5","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis","volume":"140","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.jtauto.2026.100369_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12328-017-0799-z","article-title":"Genetics and epigenetics in the pathogenesis of primary biliary cholangitis","volume":"11","author":"Joshita","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100369_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jtauto.2026.100369_bib8","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence and mortality of autoimmune hepatitis in England 1997\u20102015. A population\u2010based cohort study","volume":"40","author":"Gr\u00f8nb\u00e6k","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of Autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-333171","article-title":"British society of gastroenterology guidelines for diagnosis and management of autoimmune hepatitis","author":"Gleeson","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100369_bib12","first-page":"623","article-title":"Hellenic association for the study of the liver (HASL): revised clinical practice guidelines for autoimmune hepatitis","volume":"37","author":"Dalekos","year":"2024","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100369_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jtauto.2026.100369_bib14","series-title":"Atlas Tissue Autoantibodies, A. R. Bradwell","article-title":"Autoimmune liver diseases","author":"Hughes","year":"2008"},{"key":"10.1016\/j.jtauto.2026.100369_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1515\/cclm-2018-0807","article-title":"Standardization and harmonization of autoimmune diagnostics","volume":"56","author":"Jacobs","year":"2018","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100369_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib19","article-title":"Meta-analysis: Diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100369_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.jtauto.2026.100369_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jtauto.2026.100369_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00351174","article-title":"Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens","volume":"23","author":"Obermayer-Straub","year":"1996","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jtauto.2026.100369_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","article-title":"Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis","volume":"3","author":"Fabien","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100369_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano\u2010Loza","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti\u2010 SLA\/LP alone or in combination with anti\u2010Ro52 and fine specificity of anti\u2010Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib29","article-title":"Evaluation of autoimmune liver disease antibodies in hepatitis patients","volume":"19","author":"Kim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100369_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2249.2001.01568.x","article-title":"Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis","volume":"125","author":"Murota","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-006-9045-z","article-title":"Double reactivity against actin and \u03b1-Actinin defines a severe form of autoimmune hepatitis type 1","volume":"26","author":"Paul","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/cei\/uxad114","article-title":"Autoantibodies to beta tubulin in autoimmune liver diseases\u2014Relation to pANCA and clinical relevance","volume":"216","author":"Preu\u00df","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","author":"Aguilera","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1023\/B:DDAS.0000026306.36511.c8","article-title":"Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis","volume":"49","author":"Czaja","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jtauto.2026.100369_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-021-00573-7","article-title":"Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis","volume":"17","author":"Granito","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1746.1998.tb00673.x","article-title":"Characterization of anti\u2010histone antibodies in patients with type 1 autoimmune hepatitis","volume":"13","author":"Chen","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/hepr.12130","article-title":"Anti\u2010nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity","volume":"44","author":"Yokokawa","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jtauto.2026.100369_bib38","series-title":"Adv. Clin. Chem.","first-page":"127","article-title":"Autoantibodies in autoimmune liver disease","author":"Czaja","year":"2005"},{"key":"10.1016\/j.jtauto.2026.100369_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15321819.2013.879450","article-title":"Detection of anti-lactoferrin antibodies and anti-myeloperoxidase antibodies in autoimmune hepatitis: a retrospective study","volume":"35","author":"Tan","year":"2014","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.jtauto.2026.100369_bib40","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2026.100369_bib41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib42","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"Mieli-Vergani","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100369_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5409\/wjcp.v12.i3.77","article-title":"Seronegative autoimmune hepatitis in childhood","volume":"12","author":"Islek","year":"2023","journal-title":"World J. Clin. Pediatr."},{"key":"10.1016\/j.jtauto.2026.100369_bib45","first-page":"459","article-title":"Seronegative autoimmune hepatitis","volume":"11","author":"Bhumi","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody-negative autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jtauto.2026.100369_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.51821\/84.2.305","article-title":"Seronegative autoimmune hepatitis in children: a single-center experience","volume":"84","author":"Islek","year":"2021","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"10.1016\/j.jtauto.2026.100369_bib48","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib49","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100369_bib50","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100369_bib51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00313020903071413","article-title":"F-actin reactive smooth muscle antibody in subjects with normal liver function","volume":"41","author":"Toh","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.jtauto.2026.100369_bib52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM199711133372007","volume":"337","author":"Toh","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2026.100369_bib53","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4\u2010Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2026.100369_bib54","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2026.100369_bib55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2016.03.001","article-title":"Do anti-smooth muscle antibodies predict development of autoimmune hepatitis in patients with normal liver function? - a retrospective cohort review","volume":"15","author":"Healey","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100369_bib56","first-page":"869","article-title":"Autoimmune hepatitis associated with other autoimmune diseases: a critical review","volume":"13","author":"Zhao","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib57","doi-asserted-by":"crossref","DOI":"10.21037\/tgh-24-140","article-title":"Overlap syndromes in autoimmune liver disease: a review","volume":"10","author":"Sohal","year":"2025","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib58","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/liv.15382","article-title":"Extrahepatic autoimmune diseases in autoimmune hepatitis: effect on mortality","volume":"42","author":"Birn\u2010Rydder","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jtauto.2026.100369_bib60","first-page":"449","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jtauto.2026.100369_bib61","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/liv.15000","article-title":"High prevalence of celiac disease in autoimmune hepatitis: systematic review and meta\u2010analysis","volume":"41","author":"Hagg\u00e5rd","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/MEG.0000000000000172","article-title":"Seroprevalence of celiac disease in patients with autoimmune hepatitis","volume":"26","author":"Van Gerven","year":"2014","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib63","first-page":"35","article-title":"Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management, pediatr","volume":"14","author":"Panetta","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jtauto.2026.100369_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100369_bib65","article-title":"Prognostic implications of antibodies to soluble liver antigen in autoimmune hepatitis: a PRISMA-compliant meta-analysis","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2026.100369_bib66","first-page":"368","article-title":"Permanent immunosuppression in SLA\/LP-positive autoimmune hepatitis is required although overall response and survival are similar","volume":"40","author":"Zachou","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jtauto.2026.100369_bib67","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MEG.0000000000002747","article-title":"The frequency and clinical significance of antibodies to soluble liver antigen\/liver pancreas in autoimmune hepatitis: a prospective single-center study","volume":"36","author":"Y\u00fcksekyayla","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2023.02.017","article-title":"Paediatric autoimmune hepatitis: time to change the textbooks?","volume":"78","author":"Lohse","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib69","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","volume":"78","author":"Maggiore","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib70","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux-Henno","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1089-3261(02)00019-3","article-title":"Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features","volume":"6","author":"McFarlane","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100369_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100369_bib74","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1515\/cclm-2023-0209","article-title":"Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP","volume":"61","author":"Bonroy","year":"2023","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100369_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2026.100369_bib76","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib77","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaut.2018.10.004","article-title":"The clinical usage and definition of autoantibodies in immune-mediated liver disease: a comprehensive overview","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100369_bib78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-021-08888-9","article-title":"Autoimmune hepatitis: serum autoantibodies in clinical practice","volume":"63","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib79","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.46.4.553","article-title":"Liver\/Kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane","volume":"46","author":"Muratori","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100369_bib80","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/Kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100369_bib81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","article-title":"Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found","volume":"12","author":"Rigopoulou","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100369_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2009.06.035","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis","volume":"408","author":"Hausdorf","year":"2009","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.jtauto.2026.100369_bib83","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.191254","article-title":"The diagnostic value of autoantibodies to asialoglycoprotein receptor combined with antinuclear antibody in autoimmune hepatitis","volume":"66","author":"Zhuang","year":"2020","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jtauto.2026.100369_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12016-007-8050-1","article-title":"Anti-\u03b1-Actinin antibodies cross-react with Anti-ssDNA antibodies in active autoimmune hepatitis","volume":"34","author":"Renaudineau","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2026.100369_bib85","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","article-title":"Frequency and significance of antibodies to chromatin in autoimmune hepatitis","volume":"48","author":"Czaja","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jtauto.2026.100369_bib86","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000807","article-title":"Identification of anti-DOK2 antibodies in patients with autoimmune hepatitis via a human protein microarray","volume":"9","author":"Abe","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jtauto.2026.100369_bib87","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/liv.14062","article-title":"Autoimmune hepatitis: current and future therapeutic options","volume":"39","author":"Doycheva","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib88","first-page":"4028","article-title":"Seropositivity and titers of anti-smooth muscle actin antibody are associated with relapse of type 1 autoimmune hepatitis","volume":"23","author":"Shibuki","year":"2017","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jtauto.2026.100369_bib89","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20\u2013Year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib90","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J. Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2026.100369_bib91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u201cacute\u201d type","volume":"97","author":"Ferrari","year":"2004","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"10.1016\/j.jtauto.2026.100369_bib92","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.aohep.2018.09.001","article-title":"Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes","volume":"18","author":"Aljumah","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib93","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","article-title":"Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis","volume":"43","author":"Fujiwara","year":"2008","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100369_bib94","first-page":"570","article-title":"Autoimmune hepatitis presenting as acute liver failure: a 20-year retrospective review of North America","volume":"29","author":"Enke","year":"2023","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jtauto.2026.100369_bib95","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s12072-024-10714-1","article-title":"Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF","volume":"18","author":"Tanaka","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jtauto.2026.100369_bib96","article-title":"Approach to the patient with acute severe autoimmune hepatitis","volume":"2","author":"Rahim","year":"2020","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5114\/ceh.2025.148233","article-title":"Autoimmune hepatitis: clinicopathological characteristics and histopathological diagnosis in the light of current views","volume":"11","author":"I\u017cycka-\u015awieszewska","year":"2025","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib98","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib99","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/jcm12051979","article-title":"Autoimmune hepatitis and fibrosis","volume":"12","author":"Pellicano","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2026.100369_bib100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3138\/canlivj-2023-0026","article-title":"Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver disease","volume":"7","author":"Ragheb","year":"2024","journal-title":"Can. Liver J."},{"key":"10.1016\/j.jtauto.2026.100369_bib101","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jceh.2023.03.005","article-title":"Autoantibody positivity has no impact on histological parameters in nonalcoholic fatty liver diseases","volume":"13","author":"Jain","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib102","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100369_bib103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib104","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia","volume":"7","author":"Yang","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jtauto.2026.100369_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5500\/wjt.v12.i3.59","article-title":"Autoimmune hepatitis and liver transplantation: indications, and recurrent and de novo autoimmune hepatitis","volume":"12","author":"Harputluoglu","year":"2022","journal-title":"World J. Transplant."},{"key":"10.1016\/j.jtauto.2026.100369_bib106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","article-title":"\u201cDe novo\u201d and \u201crecurrent\u201d autoimmune hepatitis after liver transplantation: a comprehensive review","volume":"66","author":"Kerkar","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100369_bib107","first-page":"34","article-title":"Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes","volume":"15","author":"Cattan","year":"2002","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"key":"10.1016\/j.jtauto.2026.100369_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-8278(00)80175-0","article-title":"Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis","volume":"33","author":"Duclos-Vall\u00e9e","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100369_bib109","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine","volume":"72","author":"Andries","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jtauto.2026.100369_bib110","first-page":"331","article-title":"Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation","volume":"68","author":"Duclos-Vall\u00e9e","year":"2005","journal-title":"Acta Gastro-Enterol. Belg"},{"key":"10.1016\/j.jtauto.2026.100369_bib111","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jtauto.2026.100369_bib112","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100369_bib113","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/life14040500","article-title":"Are gender differences important for autoimmune liver diseases?","volume":"14","author":"Floreani","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.jtauto.2026.100369_bib114","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100369_bib115","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jtauto.2026.100369_bib116","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1196\/annals.1398.041","article-title":"Identification by proteomic tool of atypical anti-liver\/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation","volume":"1109","author":"Huguet","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jtauto.2026.100369_bib117","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation","volume":"10","author":"Aguilera","year":"2004","journal-title":"Liver Transplant."},{"key":"10.1016\/j.jtauto.2026.100369_bib118","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.21152","article-title":"Progressive histological damage in liver allografts following pediatric liver transplantation","volume":"43","author":"Evans","year":"2006","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100369_bib119","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPG.0b013e31805ce219","article-title":"Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation","volume":"45","author":"Avitzur","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jtauto.2026.100369_bib120","first-page":"530","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation, Liver Transplant","volume":"15","author":"Salcedo","year":"2009","journal-title":"Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jtauto.2026.100369_bib121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0012.2010.01221.x","article-title":"Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation","volume":"25","author":"Aguilera","year":"2011","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jtauto.2026.100369_bib122","series-title":"LiverTox Clin. Res. Inf. Drug-Induc. Liver Inj., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD)","article-title":"Autoimmune hepatitis","year":"2012"},{"key":"10.1016\/j.jtauto.2026.100369_bib123","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/apt.70353","article-title":"Unveiling drug-induced autoimmune-like hepatitis in autoimmune hepatitis patients: a multicenter retrospective study","volume":"63","author":"Arvaniti","year":"2026","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2026.100369_bib124","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep4.1582","article-title":"Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype","volume":"4","author":"Lammert","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jtauto.2026.100369_bib125","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jtauto.2026.100369_bib126","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org, management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.jtauto.2026.100369_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002435","article-title":"Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jtauto.2026.100369_bib128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"10.1016\/j.jtauto.2026.100369_bib129","article-title":"Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort","volume":"5","author":"Hountondji","year":"2023","journal-title":"JHEP Rep. Innov. Hepatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:25:25Z","timestamp":1781659525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":129,"alternative-id":["S2589909026000225"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100369","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in the follow-up of autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100369"}}